BMRN vs EXTR · P/E 40, rev $1.76B vs P/E 257, rev $1.28B
Biomarin Pharmaceutical Inc (BMRN) versus Extreme Networks Inc (EXTR) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Extreme Networks Inc (EXTR) is a communication equipment company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported EXTR revenue for 2026-06-30 was $1.28B. Net income was $42.1M. Revenue was up 12.6% from 2025-06-30 to 2026-06-30. EXTR currently screens at market cap $4.03B and trailing P/E 256.9.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. EXTR currently screens at market cap $4.03B and trailing P/E 256.9.
Not investment advice. Open the BMRN and EXTR stock pages for the full models.
Not investment advice.